Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.26−0.02 (-5.45%)
Close on Nov 20, 2026Market cap $41.52MP/E –Yield –
Mereo BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Mereo BioPharma's price to sales ratio was 85.6× on Apr 30, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 85.6× | −357.0 |
| 2025 | Jan 31, 2025 | 442.5× | +387.4 |
| 2024 | Jul 31, 2024 | 55.1× | – |
See a number that looks wrong?